Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider David K. Morris Sells 369,212 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider David K. Morris sold 369,212 shares of Guardian Pharmacy Services stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $20.16, for a total transaction of $7,443,313.92. Following the completion of the transaction, the insider now owns 283,042 shares in the company, valued at approximately $5,706,126.72. This trade represents a 56.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Guardian Pharmacy Services Price Performance

Shares of NYSE:GRDN traded up $0.49 during trading on Tuesday, hitting $21.78. 290,686 shares of the stock were exchanged, compared to its average volume of 169,453. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91. The company has a fifty day moving average price of $23.18 and a two-hundred day moving average price of $22.01.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. As a group, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently commented on GRDN shares. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Truist Financial restated a "buy" rating and issued a $28.00 price target (up from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Finally, Raymond James set a $28.00 target price on Guardian Pharmacy Services and gave the company an "outperform" rating in a report on Wednesday, May 14th.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the company. R Squared Ltd purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter worth $30,000. BNP Paribas Financial Markets purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter valued at $37,000. Compass Financial Services Inc acquired a new position in Guardian Pharmacy Services in the fourth quarter valued at $58,000. JPMorgan Chase & Co. purchased a new position in Guardian Pharmacy Services during the fourth quarter worth about $77,000. Finally, Quantbot Technologies LP acquired a new stake in Guardian Pharmacy Services in the 4th quarter worth about $81,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.